Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
9.14
-0.02 (-0.22%)
At close: Dec 12, 2025, 4:00 PM EST
9.10
-0.04 (-0.44%)
Pre-market: Dec 15, 2025, 4:37 AM EST
Grifols Employees
Grifols had 23,737 employees as of December 31, 2023. The number of employees decreased by 2,577 or -9.79% compared to the previous year.
Employees
23,737
Change (1Y)
-2,577
Growth (1Y)
-9.79%
Revenue / Employee
$371,615
Profits / Employee
$18,423
Market Cap
7.73B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 23,737 | -2,577 | -9.79% |
| Dec 31, 2022 | 26,314 | 3,080 | 13.26% |
| Dec 31, 2021 | 23,234 | -421 | -1.78% |
| Dec 31, 2020 | 23,655 | -348 | -1.45% |
| Dec 31, 2019 | 24,003 | 2,773 | 13.06% |
| Dec 31, 2018 | 21,230 | 2,934 | 16.04% |
| Dec 31, 2017 | 18,296 | 3,419 | 22.98% |
| Dec 31, 2016 | 14,877 | 140 | 0.95% |
| Dec 31, 2015 | 14,737 | 757 | 5.41% |
| Dec 31, 2014 | 13,980 | 2,201 | 18.69% |
| Dec 31, 2013 | 11,779 | 671 | 6.04% |
| Dec 31, 2012 | 11,108 | -122 | -1.09% |
| Dec 31, 2011 | 11,230 | 5,262 | 88.17% |
| Dec 31, 2010 | 5,968 | -16 | -0.27% |
| Dec 31, 2009 | 5,984 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GRFS News
- 6 days ago - Grifols: Positive/Neutral Scenario Posits An Upside - Seeking Alpha
- 5 weeks ago - Grifols, S.A. (GIKLY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Top Biotech Stocks Riding The Rally - Seeking Alpha
- 6 weeks ago - 4 Best Value And Growth Stocks (Yes, They Can Coexist) - Seeking Alpha
- 2 months ago - Spanish court summons Gotham City founder in Grifols share price probe - Reuters
- 2 months ago - My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
- 2 months ago - Grifols: Significant Upside Likely Materializing - Seeking Alpha
- 6 months ago - XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology - GlobeNewsWire